Telix Pharmaceuticals Ltd
TLX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002007191
No open-market purchases or sales by Telix Pharmaceuticals Ltd insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $36.6M in total; no superinvestor holds it.
Other share classesTLPPF
Holders of 5% or more of TLX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Telix Pharmaceuticals Ltd, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Behrenbruch Christian | 13G | 6.97%23.3M shares | New | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
| Kluge Andreas | 13G | 6.78%22.7M shares | New | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Telix Pharmaceuticals Ltd, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 20257:00 AM ET | Behrenbruch Christianand 1 other | 13G | 6.97%23.3M shares | New | Nov 12, 2024 | SEC |
| Feb 14, 20257:00 AM ET | Kluge Andreasand 1 other | 13G | 6.78%22.7M shares | New | Nov 12, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Telix Pharmaceuticals Ltd shares.
No Form 144 notices for Telix Pharmaceuticals Ltd are on file.